Buprenorphine is sold under which brand name for initial treatment of opiate addiction?

Buprenorphine is sold under the brand name Subutex for the initial treatment of opiate addiction. Subutex is specifically formulated for the management and treatment of opioid dependence and contains buprenorphine as its active ingredient. This medication acts as a partial agonist at the mu-opioid receptor, which helps to alleviate withdrawal symptoms and cravings without producing the same high as full agonists like heroin or oxycodone.

Suboxone, while also a brand that contains buprenorphine, includes naloxone to deter misuse and is often used in maintenance therapy rather than initial treatment. Other options, such as Buspar and Lexapro, are unrelated to opiate addiction treatment, with Buspar being an anxiolytic and Lexapro an antidepressant, further confirming that Subutex is the appropriate brand name for the initial treatment of opiate addiction.